Is TWST research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TWST. It does not provide personalized investment advice.

TWST (Twist Bioscience Corporation Common Stock) Stock Analysis - Financials

Twist Bioscience Corporation Common Stock (TWST) is a publicly traded Healthcare sector company. As of September 9, 2026, TWST trades at $127.35 with a market cap of $8.21B and a P/E ratio of -57.74. TWST moved +0.00% today. Year to date, TWST is +303.72%; over the trailing twelve months it is +387.85%. Its 52-week range spans $23.30 to $155.44. Analyst consensus is strong buy with an average price target of $112.00. Rallies surfaces TWST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TWST's key financials?

TWST financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TWST recently traded at $127.35. Market cap is $8.21B. P/E ratio is -57.74. Revenue is $431.80M.

TWST Key Metrics

Key financial metrics for TWST
Metric	Value
Price	$127.35
Market Cap	$8.21B
P/E Ratio	-57.74
EPS	$-2.22
Dividend Yield	0.00%
52-Week High	$155.44
52-Week Low	$23.30
Volume	34.45K
Avg Volume	0
Revenue (TTM)	$431.80M
Net Income	$-136.72M
Gross Margin	51.97%

TWST Analyst Consensus

9 analysts cover TWST: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $112.00.

Common questions about TWST

What are TWST's key financials?: TWST financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TWST recently traded at $127.35. Market cap is $8.21B. P/E ratio is -57.74. Revenue is $431.80M.
Is TWST research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TWST. It does not provide personalized investment advice.